Novoflon (Fluconazole)

Fluconazole blocks the fungal enzyme 14α‑demethylase, an essential component of the ergosterol synthesis pathway. By preventing ergosterol formation, the drug disrupts the integrity of the fungal cell membrane, leading to impaired growth or death of susceptible fungi.

The dosage of Novoflon is individualized by the treating physician according to the type and severity of the infection, patient age, weight, renal and hepatic function, and any concomitant medications. Only a qualified healthcare professional should determine the appropriate regimen.

Fluconazole is classified as a pregnancy category C drug, meaning risk cannot be ruled out. It should be used only when the potential benefit justifies the potential fetal risk. Limited data are available for breastfeeding; the decision to continue treatment should be made by the prescriber after evaluating the mother‑infant risk‑benefit profile.

To request Novoflon, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Novoflon (fluconazole) shares the azole class mechanism of inhibiting ergosterol synthesis, similar to itraconazole or voriconazole. Compared with broader‑spectrum azoles, fluconazole has a more favorable safety profile and fewer drug‑interaction concerns but may be less effective against certain resistant fungal species. Choice of agent depends on pathogen susceptibility and clinical context.

Novoflon should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Novoflon is supplied as an oral tablet that is swallowed whole with water. The exact timing (with or without food) and frequency are specified by the prescribing clinician based on the infection being treated and patient-specific factors.

Serious adverse events, although rare, include hepatotoxicity (elevated liver enzymes or liver failure), severe skin reactions such as Stevens‑Johnson syndrome, and cardiac QT‑interval prolongation. Patients should be monitored for signs of liver dysfunction, rash, or cardiac symptoms, and therapy should be discontinued if these occur.

Novoflon is contraindicated in individuals with a known hypersensitivity to fluconazole or any other azole antifungal. Caution is also advised for patients with severe liver disease, and it should be avoided in those taking medications that have a major interaction unless the prescriber decides the benefits outweigh the risks.